Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubitecan in Advanced Gastric Carcinoma
NCT00005876Phase 2Unknown
- Sponsor
- Astex Pharmaceuticals
- Start
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Astex Pharmaceuticals. Status: unknown.
02
Drugs
rubitecan
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00005876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005876.